Skip to search formSkip to main contentSkip to account menu

Bexsero

National Institutes of Health

Related topics

Related topics

3 relations
4CMenB vaccine

Broader (2)

Neisseria meningitidis serogroup B recombinant NADA fusion protein antigenNeisseria meningitidis serogroup B recombinant NHBA fusion protein antigen

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Strain coverage of Bexsero vaccine assessed by whole-genome sequencing over a cohort of invasive meningococci of serogroups B and W isolated in Switzerland.
2019
2019
Health impact and cost-effectiveness of introducing the vaccine (Bexsero) against MenB disease into the Brazilian immunization programme.
2019
2019
Measurement of surface protein antigens, PorA and PorB, in Bexsero vaccine using quantitative mass spectrometry.
2018
2018
G264(P) Menb (bexsero) immunisation side effects in extremely premature infants (<28 weeks)
Background The UK on 01 September 2015 became the first country to introduce Meningococcal B (Bexsero) vaccine into the national… 
2018
2018
Quality by design approach in the development of an ultra-high-performance liquid chromatography method for Bexsero meningococcal group B vaccine.
2017
2017
Crystal structures of human Fabs targeting the Bexsero meningococcal vaccine antigen NHBA
The crystal structures and functional characterization of two anti-NHBA human Fabs provide insight into the recognition by human… 
Review
2016
Review
2016
[Bexsero, a novel vaccine against meningococcus].
Meningococcus B is the most prevalent Neisseria meningitidis serogroup isolated in Hungary. Bexsero is one of the vaccines… 
Review
2016
Review
2016
G229(P) Fever with the new MenB vaccine – what should we do?
Background From September 2015 babies born on or after 1/7/15 are being offered the MenB (meningococcal group B) vaccine, bexsero… 
Review
2015
Review
2015
Meningococcal B vaccination strategies and their practical application in Italy
Summary Immunisation against meningococcal meningitis has a long history, which has passed through several phases: the studies by… 
2014
2014
UK poised to make decision on 4CMenB vaccine
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)